Please use this identifier to cite or link to this item:
|Title:||The Singapore 5-Fluorouracil Trabeculectomy Study. Effects on Intraocular Pressure Control and Disease Progression at 3 Years||Authors:||Wong, T.T.
|Issue Date:||2009||Citation:||Wong, T.T., Aung, T., Htoon, H.M., Oen, F.T.S., Chew, P.T.K., Seah, S.K.L., Khaw, P.T., Foster, P.J., Gazzard, G., Minassian, D., Husain, R., Devereux, J.G., Tan, S.-B. (2009). The Singapore 5-Fluorouracil Trabeculectomy Study. Effects on Intraocular Pressure Control and Disease Progression at 3 Years. Ophthalmology 116 (2) : 175-184. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ophtha.2008.09.049||Abstract:||Purpose: To report 3-year results of a randomized, controlled trial comparing the use of a single application of 5-fluorouracil (5-FU) with placebo in trabeculectomy surgery. Design: Prospective, randomized, double-blinded treatment trial. Participants: Two hundred forty-three Asian patients with primary open-angle or primary angle-closure glaucoma undergoing primary trabeculectomy. Methods: One eye of each patient was randomized to receive either intraoperative 5-FU or normal saline (placebo) during trabeculectomy. Main Outcome Measures: Primary outcome measure was the level of intraocular pressure (IOP). Secondary outcomes were progression of visual field loss, rates of adverse events, and interventions after surgery. Results: Of the 288 eligible patients, 243 were enrolled and 228 completed 3 years follow-up; 120 patients received 5-FU and 123 received placebo. Trial failure, according to predefined IOP criteria, was lower in the 5-FU group compared with the placebo group, although the difference was only significant with a failure criterion of IOP >17 mmHg (P = 0.0154). There was no significant difference in progression of optic disc and/or visual field loss over 36 months between 5-FU and placebo (relative risk [RR], 0.67; 95% confidence interval [CI], 0.34-1.31; P = 0.239). Uveitis occurred more often in the 5-FU-treated group (14/115 [12%] vs 5/120 [4%]; P = 0.032). Conclusions: This is the first masked, prospective, randomized trial reporting the effect of adjunctive 5-FU in trabeculectomy surgery in an East Asian population. The trial shows that an increased success rate can be achieved for several years after a single intraoperative treatment with 5-FU. We conclude that 5-FU is relatively safe and can be routinely used in low-risk East Asian patients. Financial Disclosure(s): The authors have no proprietary or commercial interest in any materials discussed in this article. © 2009 American Academy of Ophthalmology.||Source Title:||Ophthalmology||URI:||http://scholarbank.nus.edu.sg/handle/10635/26514||ISSN:||01616420||DOI:||10.1016/j.ophtha.2008.09.049|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.